News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Cavit Sciences, Inc. Announces Additional Compound Information
August 3, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DELRAY BEACH, FL--(MARKET WIRE)--Aug 3, 2007 -- Cavit Sciences, Inc. ("Cavit") (OTC BB:CVIT.OB - News) today announced the synergism of its compounds in treating and preventing degenerative diseases.
Twitter
LinkedIn
Facebook
Email
Print